Taiwan Biophotonic Co. To Launch World’s First Medical Smart Watch for Monitoring Heart Rate and Blood Oxygen

Taiwan Biophotonic Co. Receives CE Mark to Launch World's First Medical Smart Watch for Monitoring Heart Rate and Blood Oxygen

The Medical Smart Watch is Built with tBPC's Patented DOE Lens Reflective PPG Sensor Which Measures Heart Rate and Blood Oxygen on the Wrist with Medical-grade Accuracy.

 TAIPEI, Taiwan, Feb. 21, 2017 /PRNewswire/ -- Taiwan Biophotonic Co. (tBPC), a medical device company and the leading provider of non-invasive vital signs sensing solutions, today announced the CE Marking and the debut of the industry's first finger-free wrist pulse oximeter, the oCareTM Pro 100, which is a quantum leap forward in the wearable healthcare and medical devices space.

tBPC's Wrist Pulse Oximeter, the oCareTM Pro 100, provides a non-invasive, simple and reliable method to measure and record heart rate and blood oxygen saturation on the wrist, without hindering wires and a fingertip probe that clamps on the finger. This device is designed to follow adult users for use in checking and/or recording of specific physiological parameters. These users may be in hospitals, hospital-type facilities, and a home environment. Professional users can upload timely data measured during daily activities or sleeping for physical or clinical evaluation.

Click here to continue reading.